COLUMBIA, Md., Sept. 20, 2023 /PRNewswire/ -- The Maryland Stem Cell Research Commission (MSCRC) announces grant awards totaling approximately $4 million dedicated to fostering innovative research that will propel advancements in stem cell treatments and technologies across Maryland.

哥伦比亚医学博士。，2023年9月20日/PRNewswire/-马里兰州干细胞研究委员会（MSCRC）宣布拨款约400万美元，致力于促进创新研究，推动马里兰州干细胞治疗和技术的进步。

Continue Reading

继续阅读

12 outstanding scientists have been selected as recipients of these prestigious grants.

12名杰出科学家被选为这些着名资助的获得者。

Tweet this

推特这个

Maryland Stem Cell Research Commission Announces $4 Million in Grants to Drive Stem Cell Innovations

马里兰州干细胞研究委员会宣布拨款400万美元，以推动干细胞创新

12 outstanding scientists hailing from Maryland-based research institutions and companies have been selected as recipients of these prestigious grants. Among the distinguished awardees are researchers from esteemed academic institutions, such as Johns Hopkins University and the University System of Maryland, and early-stage companies, including Secretome Therapeutics, Inc.

来自马里兰州研究机构和公司的12位杰出科学家被选为这些着名资助的接受者。其中杰出的获奖者包括来自约翰霍普金斯大学和马里兰大学系统等知名学术机构的研究人员，以及包括Secretome Therapeutics，Inc。在内的早期公司。

(formerly NeoProgen), Renovate Biosciences, Inc., and Phycin, Inc.  The funds are intended to bolster the development of treatments and cures for a diverse range of illnesses including those involving the liver, eyes, blood, bones, heart, nervous system, autoimmune system, and cancer..

（前身为NeoProgen），Renview Biosciences，Inc。和Phycin，Inc。这些基金旨在支持开发各种疾病的治疗和治疗方法，包括涉及肝脏，眼睛，血液，骨骼，心脏，神经系统的疾病。，自身免疫系统和癌症。。

Notably, one-quarter of the awards support projects conducted by Maryland companies. With the exception of the Launch program, which invites applications from scientists new to the stem cell research field, this round of funding focused on fostering continued research and development on previously funded projects to bring these innovative technologies closer to clinical application, offering hope to patients presented with limited treatment options..

值得注意的是，四分之一的奖项支持由马里兰州公司开展的项目。除了邀请新进入干细胞研究领域的科学家申请的启动计划外，这一轮资金集中在促进对以前资助的项目的持续研究和开发，以使这些创新技术更接近临床应用，为患者提供希望提供有限的治疗选择。。

Ruchika Nijhara, PhD, executive director of the Maryland Stem Cell Research Fund (MSCRF), expressed pride in the achievements of these prior awardees, highlighting their progress toward clinical application with a tangible impact on patients' lives. Nijhara emphasized, 'We recognize that consistent funding plays a pivotal role in the development of affordable, life-changing therapies.

马里兰州干细胞研究基金（MSCRF）执行董事Ruchika Nijhara博士对这些先前获奖者的成就表示自豪，强调了他们在临床应用方面的进展，对患者的生活产生了切实的影响。Nijhara强调，“我们认识到，持续的资金在开发负担得起的，改变生活的疗法方面起着举足轻重的作用。

We remain steadfast in our commitment to providing vital support to researchers and companies across Maryland as they work to realize the potential of their groundbreaking stem cell-based discoveries and transformative therapies, reshaping the future of medicine.'To date, the MSCRC has dedicated over $200 million to support nearly 600 research projects.

我们仍然坚定地致力于为马里兰州的研究人员和公司提供重要支持，因为他们努力实现其突破性的基于干细胞的发现和变革疗法的潜力，重塑医学的未来迄今为止，MSCRC已投入超过2亿美元用于支持近600个研究项目。

This funding spans various stages of technology development, ranging from basic research to translational research, clinical development, and product manufacturing.  'We are thrilled to witness the remarkable strides our awardees have taken in advancing their pioneering discoveries toward clinical application.

这项资金涵盖了技术开发的各个阶段，从基础研究到转化研究，临床开发和产品制造。“我们很高兴看到我们的获奖者在推进他们在临床应用方面的开创性发现方面取得的显着进步。

We hold great hope that these groundbreaking innovations will bring about enduring improvements in patient care and overall well-being,' said Diane Hoffmann, chair of the Maryland Stem Cell Commission.The funding for the first round of FY24 was supported by a budget of $20.5 million from Gov. Wes Moore and the Maryland General Assembly.

马里兰州干细胞委员会主席戴安娜·霍夫曼（Diane Hoffmann）说，我们非常希望这些开创性的创新将为患者护理和整体健康带来持久的改善.24年度第一轮的资金得到预算的支持。来自Wes Moore政府和马里兰大会的2050万美元。

This reflects the continuing dedication of Maryland's leadership to the advancement of stem cell research and the quest for groundbreaking medical innovations. The Commission is preparing to release Requests for Applications (RFAs) for its second round of FY24 funding, anticipating a continued acceleration of pioneering research and innovative cures through the various programs of the MSCRF.The 12 fund.

这反映了马里兰州领导层不断致力于干细胞研究的进步和对开创性医疗创新的追求。该委员会正在准备发布第二轮“十二四”资助申请（RFAs），预计将通过MSCRF.12基金的各种计划继续加快开创性研究和创新治疗。

Launch: This award is to encourage new and new-to-the-field faculty to bring innovative research and technology to the regenerative medicine field. Totaling $1,394,899, the four Launch Award recipients are Drs. Mark Ranek, Xiaoning Han, Ali Shakeri-Zadeh, and Luo Gu from Johns Hopkins University.

启动：本奖项旨在鼓励现场教师的新旧人员为再生医学领域带来创新研究和技术。共获得1394899美元，四位获奖者是约翰霍普金斯大学的Mark Ranek博士，韩晓宁博士，Ali Shakeri Zadeh博士和罗谷博士。

Commercialization: This award is for Maryland-based companies to develop diagnostics, treatments, and cures using stem cells. Totaling $1,196,000, the three Commercialization Award recipients are Secretome Therapeutics, Inc. (Dr. Rachana Mishra), Renovate Biosciences, Inc. (Dr. Bhanu Telugu), and Phycin, Inc.

商业化：该奖项适用于马里兰州的公司开发使用干细胞的诊断，治疗和治疗。这三个商业化奖获得者总计1196000美元，分别是Secretome Therapeutics，Inc.（Rachana Mishra博士），Renight Biosciences，Inc.（Bhanu Telugu博士）和Phycin，Inc。

(Dr. Jun Wang)..

（王军博士）。。

Validation: This award supports faculty at Maryland-based Universities/Research institutes with IP for human stem cell-based technologies that require additional validation. Totaling $479,990, the two Validation award recipients are Drs. Sheikh Amer Riazuddin and Elias Zambidis from Johns Hopkins University..

验证：该奖项支持马里兰州大学/研究机构的教师使用IP进行基于人类干细胞的技术，这些技术需要额外的验证。总共479990美元，两个验证奖获得者是约翰霍普金斯大学的Sheikh Amer Riazuddin博士和Elias Zambidis博士。。

Discovery: These awards fund innovative ideas to develop novel human stem cell-based technologies and cures. Totaling $344,967, the Discovery Award recipient is Dr. Satoru Otsuru from the University of Maryland, Baltimore.

发现：这些奖项资助创新思想，开发新的基于人类干细胞的技术和治疗方法。发现奖获得者总计344967美元，来自巴尔的摩马里兰大学的Satoru Otsuru博士。

Post-Doctoral Fellowship: These awards support exceptional post-doctoral fellows conducting research in Maryland. Totaling $260,000, the two Post-Doctoral Fellowship Award recipients include Dr. Hongjun Zhang from Johns Hopkins University and Dr. Joe Kodama from the University of Maryland, Baltimore..

博士后奖学金：这些奖项支持在马里兰州进行研究的杰出博士后研究员。两名博士后奖学金获得者总计26万美元，包括约翰霍普金斯大学的张洪军博士和巴尔的摩马里兰大学的Joe Kodama博士。。

About TEDCOTEDCO, the Maryland Technology Development Corporation, enhances economic empowerment growth through the fostering of an inclusive entrepreneurial innovation ecosystem. TEDCO identifies, invests in, and helps grow technology and life science-based companies in Maryland. Learn more at www.tedcomd.com.Media ContactTammi Thomas, Chief Development & Marketing Officer, TEDCO, [email protected]About the Maryland Stem Cell Research CommissionThe Maryland Stem Cell Research Commission is focused on identifying and fostering cutting-edge research and innovation in the field of regenerative medicine in Maryland.

关于马里兰州技术发展公司TEDCOTEDCO，通过建立包容性创业创新生态系统，加强经济赋权增长。TEDCO在马里兰州识别，投资并帮助成长技术和生命科学公司。了解更多信息，请访问www.tedcomd.com.Media联系TAMMI Thomas，TEDCO首席开发和营销官，[电子邮件保护]关于马里兰州干细胞研究委员会马里兰州干细胞研究委员会专注于识别和促进尖端研究和马里兰州再生医学领域的创新。

Our Accelerating Cures initiative comprises programs that help transition human stem cell-based technologies from the bench to the bedside as well as mechanisms to build and grow stem cell companies in Maryland. Visit us at www.mscrf.org to learn more about our funding opportunities.MSCRF ContactRuchika Nijhara, PhD, MBA, Executive Director, MSCRF, [email protected] SOURCE Maryland Stem Cell Research Commission.

我们的加速治疗计划包括帮助将人类干细胞技术从实验室过渡到床边的计划，以及在马里兰州建立和发展干细胞公司的机制。请访问我们的www.mscrf.org了解更多关于我们的资助机会。MSCRF ContactRuchika Nijhara博士，MBA，MSCRF执行董事，[电子邮件保护]来源马里兰州干细胞研究委员会。